118 related articles for article (PubMed ID: 8691205)
1. Synthesis and evaluation of 3',5'-di-tert-butyl-4'-hydroxyflavones as potential inhibitors of low density lipoprotein (LDL) oxidation.
Lewin G; Rolland Y; Privat S; Breugnot C; Lenaers A; Vilaine JP; Baltaze JP; Poisson J
J Nat Prod; 1995 Dec; 58(12):1840-7. PubMed ID: 8691205
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on LDL oxidation.
Jeong TS; Kim JR; Kim KS; Cho KH; Bae KH; Lee WS
Bioorg Med Chem; 2004 Aug; 12(15):4017-23. PubMed ID: 15246079
[TBL] [Abstract][Full Text] [Related]
3. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
[TBL] [Abstract][Full Text] [Related]
4. Tiliroside and gnaphaliin inhibit human low density lipoprotein oxidation.
Schinella GR; Tournier HA; Máñez S; de Buschiazzo PM; Del Carmen Recio M; Ríos JL
Fitoterapia; 2007 Jan; 78(1):1-6. PubMed ID: 17084992
[TBL] [Abstract][Full Text] [Related]
5. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.
Iuliano L; Colavita AR; Camastra C; Bello V; Quintarelli C; Alessandroni M; Piovella F; Violi F
Br J Pharmacol; 1996 Dec; 119(7):1438-46. PubMed ID: 8968553
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of a flavonoid-rich extract on LDL oxidation.
Viana M; Barbas C; Bonet B; Bonet MV; Castro M; Fraile MV; Herrera E
Atherosclerosis; 1996 Jun; 123(1-2):83-91. PubMed ID: 8782839
[TBL] [Abstract][Full Text] [Related]
7. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J
Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
Guyton JR; Lenz ML; Mathews B; Hughes H; Karsan D; Selinger E; Smith CV
Atherosclerosis; 1995 Dec; 118(2):237-49. PubMed ID: 8770318
[TBL] [Abstract][Full Text] [Related]
9. Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation.
Kamiya K; Tanaka Y; Endang H; Umar M; Satake T
J Agric Food Chem; 2004 Sep; 52(19):5843-8. PubMed ID: 15366830
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
Yan LJ; Lodge JK; Traber MG; Packer L
Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antioxidant properties of some new flavone derivatives on lipid peroxidation in the rat liver.
Tunçbilek M; Ayhan-Kilcigil G; Ertan R; Can-Eke B; Işcan M
Pharmazie; 2000 May; 55(5):359-61. PubMed ID: 11828615
[TBL] [Abstract][Full Text] [Related]
13. Phenothiazines inhibit copper and endothelial cell-induced peroxidation of low density lipoprotein. A comparative study with probucol, butylated hydroxytoluene and vitamin E.
Breugnot C; Mazière C; Salmon S; Auclair M; Santus R; Morlière P; Lenaers A; Mazière JC
Biochem Pharmacol; 1990 Nov; 40(9):1975-80. PubMed ID: 2242028
[TBL] [Abstract][Full Text] [Related]
14. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
[TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein (LDL)-antioxidant flavonoids from roots of Sophora flavescens.
Jeong TS; Ryu YB; Kim HY; Curtis-Long MJ; An S; Lee JH; Lee WS; Park KH
Biol Pharm Bull; 2008 Nov; 31(11):2097-102. PubMed ID: 18981580
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 4,6-di-tert-butyl-2,3-dihydro-5-benzofuranols as a novel series of antiatherogenic antioxidants.
Tamura K; Kato Y; Ishikawa A; Kato Y; Himori M; Yoshida M; Takashima Y; Suzuki T; Kawabe Y; Cynshi O; Kodama T; Niki E; Shimizu M
J Med Chem; 2003 Jul; 46(14):3083-93. PubMed ID: 12825946
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids from Lindera glauca Blume as low-density lipoprotein oxidation inhibitors.
Huh GW; Park JH; Kang JH; Jeong TS; Kang HC; Baek NI
Nat Prod Res; 2014; 28(11):831-4. PubMed ID: 24499267
[TBL] [Abstract][Full Text] [Related]
18. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
19. Effects of methyl 9(or 10)-hydroxy-10(or 9)-mercaptostearate and hexadecanethioic S-acid on cupric ion- or 2,2-azo-bis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidation of low density lipoprotein.
Tanaka M; Takada K; Higuchi T; Nakagawa M; Murase M; Tobinaga S
Biol Pharm Bull; 1996 May; 19(5):692-6. PubMed ID: 8741576
[TBL] [Abstract][Full Text] [Related]
20. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
Taniguchi S; Yanase T; Kobayashi K; Takayanagi R; Haji M; Umeda F; Nawata H
Endocr J; 1994 Dec; 41(6):605-11. PubMed ID: 7704084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
